CE Mark for 'Assura' implantable defibrillators

Source：St. Jude Medical Release Date：2012-12-05 251

Medical Equipment

St. Jude Medical has announced European CE Mark approval of its Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy defibrillators (CRT-Ds). The Assura family of devices features 'ShockGuard' technology with three new algorithms to protect patients from inappropriate therapy by 74%, allowing for more effective therapy. Products currently available in Europe include the Quadra Assura CRT-D, Unify Assura CRT-D, and Fortify Assura ICD (shown).

All Assura devices can produce 40 Joules of energy, the highest delivered energy available. Aside from ShockGuard technology, the devices also include CorVue? congestion monitoring and algorithms including SecureSense? RV lead noise discrimination, which features advanced alerts and helps proactively lower the risk of lead-related complications by automatically withholding tachycardia therapy in the presence of lead noise.

“St. Jude Medical understands patients’ needs vary, which is why we are excited to add three new defibrillation technologies in Europe to our complete portfolio of cardiac rhythm management devices,” said Eric S. Fain, M.D., president of the St. Jude Medical Implantable Electronic Systems Division. “The Assura line of devices was designed for safety, reliability and extended longevity to help physicians best treat their patients.”Nike React Element